Drug Profile
Nebivolol/valsartan
Alternative Names: Byvalson; Valsartan/nebivololLatest Information Update: 18 May 2020
Price :
$50
*
At a glance
- Originator Forest Laboratories
- Developer AbbVie
- Class Antihypertensives; Benzopyrans; Ethanolamines; Ischaemic heart disorder therapies; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists; Beta 1 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Essential hypertension